Oncology Drugs Market Size, Share, Outlook, and Opportunity Analysis

 


The main types of chemotherapy, are hormone therapy, targeted therapy, lung cancer, pancreatic cancer, breast cancer, prostate cancer, ovarian cancer, colorectal cancer, gastric cancer, kidney cancer, brain tumor, thyroid cancer, skin cancer, bladder cancer, cervical cancer, blood cancer, others (Kaposi sarcoma, aids-related lymphoma, anal cancer, bone cancer, retinoblastoma, testicular cancer, hepatocellular (liver) cancer, mouth cancer, neuroblastoma).Breast cancer drugs are used to target and destroy breast cancer cells.

The oncology drugs market consists of sales of oncology drugs and related services by entities (organizations, sole traders and partnerships) that produce oncology drugs to diagnose and treat all types of cancers. This industry includes establishments that produce drugs used in chemotherapy, surgery and radiotherapies for treating pancreatic cancer, breast cancer, ovarian cancer, brain tumor, and other different cancer types.

Cancer is one of the deadliest diseases with less chance of survival as the disease progresses. International Agency for Research on Cancer published GLOBOCAN 2018 report, which estimates cancer incidence and mortality rate. This report focuses on the geographic variability of cancer incidence rate and mortality rate across 20 world regions. This report projected 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. Therefore, the high prevalence of cancer is expected to be a major factor for the growth of the global oncology drugs market.

Post a Comment

Previous Post Next Post